Risk prediction of CMV reactivation after allogeneic stem cell transplantation using five non-HLA immunogenetic polymorphisms

zu Verbundenen Objekten

Standort
Deutsche Nationalbibliothek Frankfurt am Main
ISSN
1432-0584
Umfang
Online-Ressource
Sprache
Englisch
Anmerkungen
online resource.

Erschienen in
Risk prediction of CMV reactivation after allogeneic stem cell transplantation using five non-HLA immunogenetic polymorphisms ; volume:101 ; number:7 ; day:7 ; month:5 ; year:2022 ; pages:1567-1576 ; date:7.2022
Annals of hematology ; 101, Heft 7 (7.5.2022), 1567-1576, 7.2022

Urheber
Vallejo, Miren
Muñiz, Paula
Kwon, Mi
Solán, Laura
Bailén, Rebeca
Carbonell, Diego
Chicano, María
Suárez-González, Julia
Catalán, Pilar
Bellón, José María
Triviño, Juan Carlos
Dorado, Nieves
Gallardo, David
Díez-Martín, José Luis
Ramírez, Natalia
Martínez-Laperche, Carolina
Buño, Ismael
Beteiligte Personen und Organisationen
SpringerLink (Online service)

DOI
10.1007/s00277-022-04841-8
URN
urn:nbn:de:101:1-2022081020114845823669
Rechteinformation
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
Letzte Aktualisierung
15.08.2025, 07:30 MESZ

Datenpartner

Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Original beim Datenpartner anzeigen

Beteiligte

  • Vallejo, Miren
  • Muñiz, Paula
  • Kwon, Mi
  • Solán, Laura
  • Bailén, Rebeca
  • Carbonell, Diego
  • Chicano, María
  • Suárez-González, Julia
  • Catalán, Pilar
  • Bellón, José María
  • Triviño, Juan Carlos
  • Dorado, Nieves
  • Gallardo, David
  • Díez-Martín, José Luis
  • Ramírez, Natalia
  • Martínez-Laperche, Carolina
  • Buño, Ismael
  • SpringerLink (Online service)

Ähnliche Objekte (12)

The indirect effects of CMV reactivation on patients following allogeneic hematopoietic stem cell transplantation: an evidence mapping

The indirect effects of CMV reactivation on patients following allogeneic hematopoietic stem cell transplantation: an evidence mapping

Rapid reconstitution of CD4 T cells and NK cells protects against CMV-reactivation after allogeneic stem cell transplantation

Rapid reconstitution of CD4 T cells and NK cells protects against CMV-reactivation after allogeneic stem cell transplantation

Cytomegalovirus (CMV) genotype in allogeneic hematopoietic stem cell transplantation

Cytomegalovirus (CMV) genotype in allogeneic hematopoietic stem cell transplantation

IL-23 plasma level is strongly associated with CMV status and reactivation of CMV in renal transplant recipients

IL-23 plasma level is strongly associated with CMV status and reactivation of CMV in renal transplant recipients

Epstein–Barr virus and cytomegalovirus reactivation after allogeneic hematopoietic cell transplantation in patients with non–Hodgkin lymphoma: the prevalence and impacts on outcomes : EBV and CMV reactivation post allo-HCT in NHL

Epstein–Barr virus and cytomegalovirus reactivation after allogeneic hematopoietic cell transplantation in patients with non–Hodgkin lymphoma: the prevalence and impacts on outcomes : EBV and CMV reactivation post allo-HCT in NHL

Immunrekonstitution CMV-spezifischer T-Zellen bei Patienten nach allogener Stammzelltransplantation : Quantifizierung mittels HLA-CMV-Tetramer-Komplexen

Hochschulschrift

Immunrekonstitution CMV-spezifischer T-Zellen bei Patienten nach allogener Stammzelltransplantation : Quantifizierung mittels HLA-CMV-Tetramer-Komplexen

Detektion CMV-spezifischer CD8+-T-Lymphozyten mittels sechs verschiedener CMV-HLA-Tetramer-Komplexe bei Patienten nach allogener Stammzelltransplantation

Hochschulschrift

Detektion CMV-spezifischer CD8+-T-Lymphozyten mittels sechs verschiedener CMV-HLA-Tetramer-Komplexe bei Patienten nach allogener Stammzelltransplantation

Prevention of CMV/EBV reactivation by double-specific T cells in patients after allogeneic stem cell transplantation: results from the randomized phase I/IIa MULTIVIR-01 study

Prevention of CMV/EBV reactivation by double-specific T cells in patients after allogeneic stem cell transplantation: results from the randomized phase I/IIa MULTIVIR-01 study

Impact of antiviral treatment on long-term prognosis in non-immunocompromised patients with CMV reactivation

Impact of antiviral treatment on long-term prognosis in non-immunocompromised patients with CMV reactivation

Association between migraine and HLA–DRB1 gene polymorphisms

Association between migraine and HLA–DRB1 gene polymorphisms

High ocular CMV copies and mismatched receipts may predict poor visual prognosis in CMV retinitis patients following allogeneic haematopoietic stem cell transplantation

High ocular CMV copies and mismatched receipts may predict poor visual prognosis in CMV retinitis patients following allogeneic haematopoietic stem cell transplantation

CTLA-4 polymorphisms and haplotype correlate with survival in ALL after allogeneic stem cell transplantation from related HLA-haplotype-mismatched donor

CTLA-4 polymorphisms and haplotype correlate with survival in ALL after allogeneic stem cell transplantation from related HLA-haplotype-mismatched donor

Verbundene Objekte